Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks. An open-label extension study
about
Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritisDisease-modifying anti-rheumatic drug use according to the 'sawtooth' treatment strategy improves the functional outcome in rheumatoid arthritis: results of a long-term follow-up study with review of the literature.Combination therapy for autoimmune diseases: the rheumatoid arthritis model.Immunomodulatory therapy for ocular inflammatory disease: a basic manual and review of the literature.Cost-effectiveness of biologic response modifiers compared to disease-modifying antirheumatic drugs for rheumatoid arthritis: a systematic review.Current immunotherapy in rheumatoid arthritis.The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review.Step-down approach using either cyclosporin A or methotrexate as maintenance therapy in early rheumatoid arthritis.A retrospective analysis of combination methotrexate-cyclosporine therapy in moderate-severe psoriasis.Iguratimod is effective in refractory rheumatoid arthritis patients with inadequate response to methotrexate-cyclosporin A-hydroxychloroquine-prednisone.Cyclosporine regimens in plaque psoriasis: an overview with special emphasis on dose, duration, and old and new treatment approaches.
P2860
Q24235784-2DD261FB-AA7A-424A-970C-31DC982A15C7Q33831409-199A5334-24ED-4E96-806B-A6F2CE1D7F55Q34309751-1F7EA107-4DDA-4316-AD16-8CFBFF8122E8Q36371451-D13C3D83-86C9-4D62-89AE-DE187402043FQ37782588-839C58FB-4D49-4C67-8F8B-68CF8B22353AQ38133655-EFD09A9E-71BA-4BA1-8A3D-67B3EC573B17Q38925320-4C3413F1-0D81-4B77-8D11-53B8055B01EDQ43947279-34CE5481-DC31-4F34-BA9D-61B976A9D872Q44714485-F91828D2-346A-4C8E-B646-12545BB5B62FQ50108347-B165D995-1C0D-44DC-AE34-FF16228FBCC5Q55119199-702D998F-7CDA-4F73-B2E3-CAA1548EE76A
P2860
Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks. An open-label extension study
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 1997
@uk
name
Combination treatment of sever ...... An open-label extension study
@en
Combination treatment of sever ...... An open-label extension study
@nl
type
label
Combination treatment of sever ...... An open-label extension study
@en
Combination treatment of sever ...... An open-label extension study
@nl
prefLabel
Combination treatment of sever ...... An open-label extension study
@en
Combination treatment of sever ...... An open-label extension study
@nl
P2093
P356
P1476
Combination treatment of sever ...... An open-label extension study
@en
P2093
C. Michael Stein
David Yocum
George Wells
Gunnar Kraag
Helen Torley
John Tesser
Oscar Gluck
Raye H. Brooks
Robert McKendry
P304
P356
10.1002/ART.1780401018
P577
1997-10-01T00:00:00Z